Ontario becomes the first province in Canada to publicly reimburse the dual immunotherapy combination for unresectable or advanced hepatocellular carcinoma This decision marks the second OPDIVO® ...
This productive discussion with FDA reviewers gives Ernest leadership renewed confidence our development plan is on the ...
RAMAT GAN, Israel, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs targeting oncological and ...
Doctors in Delhi successfully treated liver cancer in a 72-year-old high-risk patient without surgery using a minimally ...
Professor Albert Chan Chi-yan (left) and Dr Chiang Chi-leung collaborate once more to develop the innovative ‘cocktail’ strategy—Locoregional therapy and immunotherapy (LRT-IO) approach. This method ...
A new Cedars-Sinai Cancer study shows that patients with advanced liver cancer who receive immunotherapy to shrink their tumors have improved outcomes after liver transplant or tumor removal.
Mumbai, Jan 20: In a landmark medical achievement, doctors at Bai Jerbai Wadia Hospital for Children, Mumbai, have ...
Liver cancer is increasingly affecting non-drinkers in India. Doctor explains how fatty liver disease, diabetes, hepatitis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results